Skip to main content
. 2023 Oct 5;18:5625–5649. doi: 10.2147/IJN.S420312

Table 3.

IC50 (µg/mL) of Nos@AgNPs, Ch@AgNPs, 5-FU, and Doxo Against T47D, MDA-MB231, MCF-7, MCF-7ADR, Sw480, A549, HFs, and Vero Cells

Cells Nos@AgNPs Ch@AgNPs 5-FU Doxorubicin
T47D 50.02 657 12.7 < 1000
MDA-MB231 118.1 256.9 442.7 125
MCF-7 271.9 31.18 56.48 2.394
MCF-7ADR 50.41 32.919 < 1000 1000
Sw480 81.42 28.28 49.18 1000
A549 21.56 573.4 29.85 6.447
HFs 18.78 54.06 32.43 415
Vero 5.758 18.51 33.12 < 1000